32 ‘monospecific’ anti-HL-A alloantisera were absorbed in separate tests with platelets from a maximum of 56 different persons and examined for residual cytotoxicity against target lymphocytes from one or two unrelated persons having the homologous (or test) antigen. Of the 799 combinations in which platelets had the test antigen, 715 (90%) were specifically inhibited; of the 720 combinations in which platelets had the cross-reactive antigen(s) (but not the test antigen), 417 (58%) were specifically cross-inhibited; and of the 1,839 combinations in which platelets had neither the homologous nor a discernable cross-reactive antigen, 133 (7%) were cross-inhibited ‘nonspecifically’. Earlier findings of crossreactivity were confirmed, and results suggested that HL-A1, HL-A10 and W30 on platelets may cross-inhibit anti-HL-A2 antibodies; HL-A7 and W21 may crossinhibit anti-HL-A5 and anti-W5 antibodies; W16 may cross-inhibit anti-HL-A5 antibodies; and W22 may cross-inhibit anti-HL-A13 antibodies.

This content is only available via PDF.
1975
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.